Balance Sheet Ovoca Bio plc Euronext Dublin

Equities

OVXA

IE0006649010

Biotechnology & Medical Research

End-of-day quote Euronext Dublin Other stock markets 2024-02-05			5-day change	1st Jan Change
0.0100 ^EUR	-.--%		-.--%	-

Feb. 24	Talisman Metals acquires two Morocco copper licences for GBP16,000	AN
Feb. 24	Talisman Metals Starts Exploration at Fougnar Copper-silver Project in Morocco	MT

501a1a3f743193d9a0f4daa9625c486.vmzkiUzg4PqSf4UluFGw8v2tWfkx_KvamdvVXr9mKbU.8xqP2XuwhKChGeFN2mnXn8XyHclexNqf8qm4DYlSesHNLqrGCa20i-NSzA

Published financial data: OVOCA BIO PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Selling General & Admin Expenses, Total	2.2M	6.1M	5.42M	1.87M	658K
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses	-	-236K	-1.46M	-1.02M	-409K
Other Operating Expenses, Total	2.2M	5.86M	3.97M	849K	249K
Operating Income	-2.2M	-5.86M	-3.97M	-849K	-249K
Interest Expense, Total	-16K	-21K	-39K	-5K	-
Interest And Investment Income	231K	104K	4K	-	-
Net Interest Expenses	215K	83K	-35K	-5K	-
Currency Exchange Gains (Loss)	-332K	530K	-1.28M	46K	246K
EBT, Excl. Unusual Items	-2.32M	-5.25M	-5.28M	-808K	-3K
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-19K	-	-
Gain (Loss) On Sale Of Assets	4K	-	-313K	-	-
Asset Writedown	-	-	-	-4.3M	-
EBT, Incl. Unusual Items	-2.32M	-5.25M	-5.61M	-5.1M	-3K
Earnings From Continuing Operations	-2.32M	-5.25M	-5.61M	-5.1M	-3K
Earnings Of Discontinued Operations	-54K	-228K	-	402K	-743K
Net Income to Company	-2.37M	-5.48M	-5.61M	-4.7M	-746K
Minority Interest	36K	-	-	-	-
Net Income - (IS)	-2.34M	-5.48M	-5.61M	-4.7M	-746K
Net Income to Common Incl Extra Items	-2.34M	-5.48M	-5.61M	-4.7M	-746K
Net Income to Common Excl. Extra Items	-2.28M	-5.25M	-5.61M	-5.1M	-3K
Per Share Items
Net EPS - Basic	-0.09	-0.2	-0.21	-0.17	-0.03
Basic EPS - Continuing Operations	-0.08	-0.19	-0.21	-0.19	-0
Basic Weighted Average Shares Outstanding	27.19M	27.19M	27.19M	27.19M	27.19M
Net EPS - Diluted	-0.09	-0.2	-0.21	-0.17	-0.03
Diluted EPS - Continuing Operations	-0.08	-0.19	-0.21	-0.19	-0
Diluted Weighted Average Shares Outstanding	27.19M	27.19M	27.19M	27.19M	27.19M
Normalized Basic EPS	-0.05	-0.12	-0.12	-0.02	-0
Normalized Diluted EPS	-0.05	-0.12	-0.12	-0.02	-0
Supplemental Items
EBITDA	-2.13M	-5.78M	-3.62M	-549K	51K
EBITA	-2.14M	-5.78M	-3.62M	-549K	-249K
EBIT	-2.2M	-5.86M	-3.97M	-849K	-249K
EBITDAR	-2.11M	-5.72M	-3.6M	-	-
Normalized Net Income	-1.42M	-3.28M	-3.3M	-505K	-1.88K
Supplemental Operating Expense Items
General and Administrative Expenses	2.18M	6.04M	5.41M	1.87M	658K
Research And Development Expense From Footnotes	688K	3.55M	2.46M	419K	-
Net Rental Expense, Total	22K	56K	15K	-	-
Stock-Based Comp., G&A Exp. (Total)	9K	12K	4K	-	-
Total Stock-Based Compensation	9K	12K	4K	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	10.75M	6.59M	3.7M	3.34M	2.51M
Total Cash And Short Term Investments	10.75M	6.59M	3.7M	3.34M	2.51M
Other Receivables	43K	334K	1.23M	121K	58K
Notes Receivable	-	-	-	-	-
Total Receivables	43K	334K	1.23M	121K	58K
Inventory	269K	94K	43K	-	-
Other Current Assets, Total	368K	-	-	10K	90K
Total Current Assets	11.43M	7.02M	4.98M	3.47M	2.65M
Gross Property Plant And Equipment	93K	76K	51K	51K	-
Accumulated Depreciation	-86K	-58K	-51K	-51K	-
Net Property Plant And Equipment	7K	18K	0	0	-
Long-term Investments	2.33M	1.95M	-	-	-
Goodwill	3.68M	3.99M	4.24M	-	-
Other Intangibles, Total	1.02M	1.03M	189K	0	-
Deferred Charges Long-Term	577K	750K	-	-	-
Total Assets	19.04M	14.77M	9.4M	3.47M	2.65M
Liabilities
Accounts Payable, Total	358K	373K	1.17M	301K	146K
Accrued Expenses, Total	91K	181K	102K	68K	63K
Short-term Borrowings	-	-	-	-	-
Current Income Taxes Payable	-	-	113K	-	-
Other Current Liabilities	37K	787K	382K	598K	385K
Total Current Liabilities	486K	1.34M	1.77M	967K	594K
Total Liabilities	486K	1.34M	1.77M	967K	594K
Common Stock, Total	11.06M	11.06M	11.06M	11.06M	11.06M
Retained Earnings	3.04M	-2.44M	-9.73M	-14.44M	-15.8M
Treasury Stock	-547K	-547K	-547K	-547K	-
Comprehensive Income and Other	5.01M	5.36M	6.86M	6.43M	6.8M
Total Common Equity	18.55M	13.43M	7.64M	2.5M	2.06M
Minority Interest	-	-	-	-	-
Total Equity	18.55M	13.43M	7.64M	2.5M	2.06M
Total Liabilities And Equity	19.04M	14.77M	9.4M	3.47M	2.65M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	27.19M	27.19M	27.19M	27.19M	27.19M
ECS Total Common Shares Outstanding	27.19M	27.19M	27.19M	27.19M	27.19M
Book Value / Share	0.68	0.49	0.28	0.09	0.08
Tangible Book Value	13.85M	8.4M	3.21M	2.5M	2.06M
Tangible Book Value Per Share	0.51	0.31	0.12	0.09	0.08
Total Debt	0	0	0	0	0
Net Debt	-10.75M	-6.59M	-3.7M	-3.34M	-2.51M
Debt Equivalent Oper. Leases	176K	448K	120K	-	-
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	269K	94K	43K	-	-
Land - (BS)	-	-	-	-	-
Machinery, Total	93K	76K	51K	51K	-
Full Time Employees	5	10	5	5	1

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-2.34M	-5.48M	-5.61M	-4.7M	-746K
Depreciation & Amortization - CF	2K	4K	6K	-	-
Amortization of Goodwill and Intangible Assets - (CF)	69K	80K	344K	300K	-
Depreciation & Amortization, Total	71K	84K	350K	300K	-
Amortization of Deferred Charges, Total - (CF)	-	-	181K	-	-
(Gain) Loss From Sale Of Asset	4K	-	313K	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	19K	-	-
Asset Writedown & Restructuring Costs	-	-	-	4.3M	-
Provision for Credit Losses	-	-	-	-	-
Stock-Based Compensation (CF)	9K	12K	4K	-	-
Net Cash From Discontinued Operations	-10K	-	-	-	-
Other Operating Activities, Total	-265K	-104K	-	-	-
Change In Accounts Receivable	423K	77K	-899K	1.1M	63K
Change In Inventories	-66K	175K	51K	43K	-
Change In Accounts Payable	59K	855K	429K	76K	-160K
Change in Other Net Operating Assets	-	-	-	-	-293K
Cash from Operations	-2.11M	-4.38M	-5.16M	1.12M	-1.14M
Capital Expenditure	-10K	-14K	-	-	-
Sale of Property, Plant, and Equipment	-	-	1.2M	-	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-379K	-157K	-42K	-49K	-
Investment in Marketable and Equity Securities, Total	7.74M	-	347K	-	-
Other Investing Activities, Total	229K	104K	-	-	-
Cash from Investing	7.58M	-67K	1.51M	-49K	-
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	900K	40K	-
Total Debt Issued	-	-	900K	40K	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-919K	-
Total Debt Repaid	-	-	-	-919K	-
Other Financing Activities, Total	-4.09M	-	-	-	-
Cash from Financing	-4.09M	-	900K	-879K	-
Foreign Exchange Rate Adjustments	-646K	291K	-133K	-553K	375K
Miscellaneous Cash Flow Adjustments	-	-	-	-	-70K
Net Change in Cash	733K	-4.15M	-2.89M	-366K	-831K
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	-1.34M	-2.64M	-2.43M	59.25K	-546K
Unlevered Free Cash Flow	-1.33M	-2.63M	-2.41M	62.38K	-546K
Change In Net Working Capital	-354K	-1.11M	419K	-342K	390K
Net Debt Issued / Repaid	-	-	900K	-879K	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-6.37	-21.67	-20.51	-8.24	-5.08
Return on Total Capital	-6.5	-22.9	-23.54	-10.47	-6.82
Return On Equity %	-10.94	-32.81	-53.28	-100.71	-0.13
Return on Common Equity	-11.16	-32.81	-53.28	-100.71	-0.13
Short Term Liquidity
Current Ratio	23.51	5.24	2.81	3.59	4.47
Quick Ratio	22.2	5.17	2.79	3.58	4.32
Operating Cash Flow to Current Liabilities	-4.34	-3.26	-2.92	1.15	-1.91
Long Term Solvency
Total Debt/Equity	-	-	-	-	-
Total Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	2.55	9.08	18.82	27.88	22.38
EBIT / Interest Expense	-137.81	-279.05	-101.72	-169.8	-
EBITDA / Interest Expense	-133.38	-275.05	-92.74	-109.8	-
(EBITDA - Capex) / Interest Expense	-134	-275.71	-92.74	-109.8	-
Total Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	5.04	1.14	1.02	6.08	-49.14
Total Debt / (EBITDA - Capex)	-	-	-	-	-
Net Debt / (EBITDA - Capex)	5.01	1.14	1.02	6.08	-49.14
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-4.77	170.67	-37.38	-84.02	-109.29
EBITA, 1 Yr. Growth %	-4.77	170.6	-37.32	-84.05	-54.64
EBIT, 1 Yr. Growth %	-4.75	165.76	-32.3	-78.6	-70.67
Earnings From Cont. Operations, 1 Yr. Growth %	21.87	126.36	6.96	-9.05	-99.94
Net Income, 1 Yr. Growth %	48.88	134.38	2.5	-16.22	-84.13
Normalized Net Income, 1 Yr. Growth %	81.21	131.72	0.63	-84.7	-99.63
Diluted EPS Before Extra, 1 Yr. Growth %	52.97	129.75	6.96	-9.02	-99.94
Inventory, 1 Yr. Growth %	32.51	-65.06	-54.26	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	133.33	157.14	-100	-	-
Total Assets, 1 Yr. Growth %	-21.53	-22.41	-36.33	-63.13	-23.47
Tangible Book Value, 1 Yr. Growth %	-19.32	-39.34	-61.81	-22.06	-17.63
Common Equity, 1 Yr. Growth %	-16.97	-27.61	-43.15	-67.24	-17.63
Cash From Operations, 1 Yr. Growth %	-2.72	107.3	18.01	-121.59	-201.88
Capital Expenditures, 1 Yr. Growth %	-	40	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-28.53	96.83	-8.09	-102.44	-1.02K
Unlevered Free Cash Flow, 1 Yr. Growth %	-28.51	97.32	-8.56	-102.59	-974.75
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	4.69	60.54	30.19	-69.17	-87.82
EBITA, 2 Yr. CAGR %	4.69	60.53	30.24	-69.18	-73.1
EBIT, 2 Yr. CAGR %	6.36	59.1	34.13	-61.94	-74.95
Earnings From Cont. Operations, 2 Yr. CAGR %	7.76	66.09	55.6	-1.37	-97.69
Net Income, 2 Yr. CAGR %	-0.43	86.8	55	-7.33	-63.54
Normalized Net Income, 2 Yr. CAGR %	41.35	104.91	52.7	-60.76	-97.62
Diluted EPS Before Extra, 2 Yr. CAGR %	16.59	87.47	56.76	-1.35	-97.69
Inventory, 2 Yr. CAGR %	22.59	-31.95	-60.02	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	52.75	144.95	-	-	-
Total Assets, 2 Yr. CAGR %	-6.55	-21.98	-29.71	-51.55	-46.88
Tangible Book Value, 2 Yr. CAGR %	1.24	-30.04	-51.87	-45.44	-19.88
Common Equity, 2 Yr. CAGR %	0.23	-22.47	-35.85	-56.85	-48.06
Cash From Operations, 2 Yr. CAGR %	-13.75	42.01	56.4	-49.52	-53.1
Levered Free Cash Flow, 2 Yr. CAGR %	22.07	18.61	34.5	-85.03	-52.61
Unlevered Free Cash Flow, 2 Yr. CAGR %	22.04	18.77	34.32	-84.6	-52.37
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	43.25	43.69	17.3	-36.4	-79.33
EBITA, 3 Yr. CAGR %	43.23	43.67	17.33	-36.42	-64.94
EBIT, 3 Yr. CAGR %	44.75	44.33	19.67	-27.25	-65.1
Earnings From Cont. Operations, 3 Yr. CAGR %	115.07	38.01	43.43	30.1	-91.7
Net Income, 3 Yr. CAGR %	83.03	32.46	52.93	26.26	-48.54
Normalized Net Income, 3 Yr. CAGR %	128.82	66.66	61.67	-29.07	-91.7
Diluted EPS Before Extra, 3 Yr. CAGR %	112.94	46.17	55.48	30.76	-91.71
Inventory, 3 Yr. CAGR %	-	-19.32	-40.39	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	32.64	81.71	-	-	-
Total Assets, 3 Yr. CAGR %	-5.35	-12.17	-27.09	-43.31	-43.57
Tangible Book Value, 3 Yr. CAGR %	-14.81	-14.65	-42.82	-43.48	-37.41
Common Equity, 3 Yr. CAGR %	-6.09	-10.07	-30.09	-48.72	-46.47
Cash From Operations, 3 Yr. CAGR %	31.85	15.53	33.51	-19.17	-36.21
Levered Free Cash Flow, 3 Yr. CAGR %	-5.11	43.14	8.94	-64.67	-40.9
Unlevered Free Cash Flow, 3 Yr. CAGR %	-5.23	43.24	8.85	-63.97	-40.8
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	11.96	27.14	37.87	-22.37	-53.07
EBITA, 5 Yr. CAGR %	11.15	26.52	37.88	-22.38	-35.57
EBIT, 5 Yr. CAGR %	11.86	26.87	40.41	-15.31	-35.98
Earnings From Cont. Operations, 5 Yr. CAGR %	0.85	40.48	88.95	20.66	-72.49
Net Income, 5 Yr. CAGR %	1.01	41.68	71.25	14.82	-13.82
Normalized Net Income, 5 Yr. CAGR %	9.84	34.59	94.64	-6.54	-70.07
Diluted EPS Before Extra, 5 Yr. CAGR %	0.55	40.38	88.38	24.89	-71.14
Inventory, 5 Yr. CAGR %	42.36	10.91	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-64.99	-58.8	-	-	-
Total Assets, 5 Yr. CAGR %	-2.6	-9.01	-15.97	-30.77	-35.76
Tangible Book Value, 5 Yr. CAGR %	-8.38	-18.57	-32.2	-28.64	-34.56
Common Equity, 5 Yr. CAGR %	-2.86	-10.56	-19.37	-32.96	-37.92
Cash From Operations, 5 Yr. CAGR %	17.97	61.85	41.17	-17.04	-12.14
Capital Expenditures, 5 Yr. CAGR %	-	69.52	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	18.28	43.51	9.1	-41.98	-21.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	18.36	43.83	8.96	-41.3	-21.79